Lab Plastic Recycling in Medtech
Lab plastic recycling is becoming an urgent conversation in medical research and development. In this Bio Break episode, Nick Allan and Nigel Syrotuck explore the massive volume of single-use plastic in labs and discuss a new company working to close the loop through a circular economy approach.
The Scale of Plastic Waste in Labs
Every year, labs around the world consume thousands of plastic plates, gloves, and other single-use components. These materials often become biohazard waste contaminated by bacteria, fluids, or other substances. As a result, they must be incinerated at high cost, generating both financial and environmental burdens.
A Circular Economy Solution
Nick and Nigel highlight a company called Polycarbon BIN, founded in 2020 by physician scientists. Their mission is to recycle lab plastics into new lab-ready materials rather than downcycling them into unrelated products. Unlike recycled toys or consumer goods, this process aims to return plastics safely back into the scientific and medical environment.
What It Means for Medtech
The potential of lab plastic recycling goes beyond waste reduction. If successful, it could reshape sustainability practices in medical device development and laboratory operations. While questions remain about scalability and long-term performance, the approach shows promise for reducing the environmental impact of essential medical research.
This episode of Bio Break sheds light on the tension between necessary single-use plastics and the urgent need for sustainability in medtech. By following new recycling initiatives, labs may find opportunities to reduce waste without compromising safety.
Enjoying Bio Break? Sign up to get new episodes sent to your inbox.
Related Resources
Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.
Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.
Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.